Subacute sclerosing panencephalitis in Papua New Guinean children: The cost of continuing inadequate measles vaccine coverage

PLoS Neglected Tropical Diseases

Volumn 5, Issue 1, 2011, Pages

  Manning, Laurens ^a   Laman, Moses ^a,b   Edoni, Henry ^b   Mueller, Ivo ^b   Karunajeewa, Harin A ^a   Smith, David ^c   Hwaiwhanje, Ilomo ^d   Siba, Peter M ^b   Davis, Timothy M E ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d Modilon General Hospital   (Papua New Guinea)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; MEASLES VACCINE; VIRUS ANTIBODY;

ACUTE DISEASE; ANTIBODY DETECTION; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INCIDENCE; INFANT; INFECTION PREVENTION; LUMBAR PUNCTURE; MALE; MEASLES; MEASLES VACCINATION; MENINGOENCEPHALITIS; PAPUA NEW GUINEA; PATIENT ASSESSMENT; POPULATION DISTRIBUTION; PRESCHOOL CHILD; PROTEIN CEREBROSPINAL FLUID LEVEL; SCHOOL CHILD; SEROCONVERSION; SUBACUTE SCLEROSING PANENCEPHALITIS; VACCINE FAILURE; ADOLESCENT; ANIMAL; BLOOD; CEREBROSPINAL FLUID; IMMUNOLOGY; METHODOLOGY; PROSPECTIVE STUDY; UTILIZATION REVIEW; VACCINATION;

ADOLESCENT; ANIMALS; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULIN G; INCIDENCE; MALE; MEASLES VACCINE; PAPUA NEW GUINEA; PROSPECTIVE STUDIES; SUBACUTE SCLEROSING PANENCEPHALITIS; VACCINATION;

EID: 79851473292     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000932     Document Type: Article

References (48)

1. Duke T, Mgone CS (2003) Measles: not just another viral exanthem. Lancet 361: 763-773.
2. Dabbagh A, Gacic-Dobo M, Simons E, Featherstone D, Strebel P, et al. (2009) Global measles mortality, 2000-2008. MMWR Morb Mortal Wkly Rep 58: 1321-1326.
3. Warrell D, Farrar J (2003) Viral Infections of the Central Nervous System. In: Warrell D, Cox T, Firth J, Benz E, editors. Oxford textbook of medicine. 4th ed Oxford Oxford University Press pp. 1138-1139.
4. Mgone CS, Mgone JM, Takasu T, Miki K, Kawanishi R, et al. (2003) Clinical presentation of subacute sclerosing panencephalitis in Papua New Guinea. Trop Med Int Health 8: 219-227.
5. Sanders RC, Brian M, Rongap A, Watt PD, Alpers MP (1990) High incidence of subacute sclerosing panencephalitis (SSPE) in young children in Papua New Guinea. Med J Aust 153: 740.
6. Takasu T, Mgone JM, Mgone CS, Miki K, Komase K, et al. (2003) A continuing high incidence of subacute sclerosing panencephalitis (SSPE) in the Eastern Highlands of Papua New Guinea. Epidemiol Infect 131: 887-898.
7. Paediatrics Society of PNG (2005) Standard treatment for common illnesses of children in PNG. 8th edition. Port Moresby.
8. National Statistical Office of Papua New Guinea (2002) Papua New Guinea 2000 census. Port Moresby Government of Papua New Guinea.
9. Duke T (2003) The crisis of measles and the need to expand the ways of delivering vaccines in Papua New Guinea. P N G Med J 46: 1-7.
10. Senn N, Riddell M, Omena M, Siba P, Reeder J, et al. (2010) Measles in Papua New Guinea: An age-specific serological survey. Vaccine 28: 1819-1823.
11. World Health Organization (2009) WHO/UNICEF Review of National Immunization Coverage 1980-2008: Papua New Guinea. Available at: http://www.who.int/immunization_monitoring/data/png.pdf. Accessed August 1, 2010.
12. World Health Organization (2009) Immunization surveillance, assessment and monitoring: Papua New Guinea reported cases. Available at: http://apps.who.int/immunization_monitoring/en/globalsummary/timeseries/tsincidencebycountry.cfm?C=PNG. Accessed August 1, 2010.
13. World Health Organization Western Pacific Region (2008) Expanded programme on immunization. National Immunization Data- EPI Summaries by Country. Available at: http://www.wpro.who.int/NR/rdonlyres/9DEB2F01-F04F-4F5D-8AA3-93574BC1FF94/0/EPICountryPosterdatafor2008PNG.pdf. Accessed August 1, 2010.
14. Barkin RM, Conrad JL (1973) Current status of measles in the United States. J Infect Dis 128: 353-356.
15. De Francisco A, Fauveau V, Sarder AM, Chowdhury HR, Chakraborty J, et al. (1994) Measles in rural Bangladesh: issues of validation and age distribution. Int J Epidemiol 23: 393-399.
16. World Health Organization (2006) The WHO Child Growth Standards. Available at: http://www.who.int/childgrowth/standards/en. Accessed August 1, 2010.
17. Molyneux ME, Taylor TE, Wirima JJ, Borgstein A (1989) Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. Q J Med 71: 441-459.
18. World Health Organization CDC (2000) Severe falciparum malaria. Trans R Soc Trop Med Hyg 94 (Suppl 1): S1-90.
19. Karnovsky DB, Burchenal JH (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod C, editors. Evaluation of Chemotherapeutic Agents New York Columbia University Press.
20. Laman M, Manning L, Hwaiwhange I, Vince J, Aipit S, et al. (2010) Lumbar puncture in children from an area of malaria endemicity who present with a febrile seizure. Clin Infect Dis 51: 534-540.
21. Tageo.com (2009) A database of geographic coordinate information. Available at: http://www.tageo.com/index-e-pp-v-12.htm?Madang. Accessed August 1, 2010.
22. Lucas KM, Sanders RC, Rongap A, Rongap T, Pinai S, et al. (1992) Subacute sclerosing panencephalitis (SSPE) in Papua New Guinea: a high incidence in young children. Epidemiol Infect 108: 547-553.
23. Miller C, Andrews N, Rush M, Munro H, Jin L, et al. (2004) The epidemiology of subacute sclerosing panencephalitis in England and Wales 1990-2002. Arch Dis Child 89: 1145-1148.
24. Beersma MF, Galama JM, Van Druten HA, Renier WO, Lucas CJ, et al. (1992) Subacute sclerosing panencephalitis in The Netherlands-1976-1990. Int J Epidemiol 21: 583-588.
25. Bass AG (1993) Vaccines in the national immunization programme. P N G Med J 36: 141-157.
26. Wirkas T, Toikilik S, Miller N, Morgan C, Clements CJ (2007) A vaccine cold chain freezing study in PNG highlights technology needs for hot climate countries. Vaccine 25: 691-697.
27. Kurubi J, Vince J, Ripa P, Tefuarani N, Riddell M, et al. (2009) Immune response to measles vaccine in 6 month old infants in Papua New Guinea. Trop Med Int Health 14: 167-173.
28. Gans H, Arvin A, Galinus J, Logan L, DeHovitz R, et al. (1998) Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months. JAMA 280: 527-532.
29. Maldonado YA, Lawrence EC, DeHovitz R, Hartzell H, Albrecht P (1995) Early loss of passive measles antibody in infants of mothers with vaccine-induced immunity. Pediatrics 96: 447-450.
30. Farrington CP (1991) Subacute sclerosing panencephalitis in England and Wales: transient effects and risk estimates. Stat Med 10: 1733-1744.
31. Mgone JM, Mgone CS, Duke T, Frank D, Yeka W (2000) Control measures and the outcome of the measles epidemic of 1999 in the Eastern Highlands Province. P N G Med J 43: 91-97.
32. Griffin DE (2009) Emergence and re-emergence of viral diseases of the central nervous system. Prog Neurobiol.
33. Saha V, John TJ, Mukundan P, Gnanamuthu C, Prabhakar S, et al. (1990) High incidence of subacute sclerosing panencephalitis in south India. Epidemiol Infect 104: 151-156.
34. Cianchetti C, Ferrante P, Marrosu MG (1986) Subacute sclerosing panencephalitis in Italy. An epidemiological study. Acta Neurol Scand 73: 160-167.
35. Cianchetti C, Cao A, Mastropaolo C, Corda R (1979) Subacute sclerosing panencephalitis in Sardinia. Lancet 1: 829.
36. Soffer D, Rannon L, Alter M, Kahana E, Feldman S (1975) Subacute sclerosing panencephalitis: incidence among ethic groups in Israel. Isr J Med Sci 11: 1-4.
37. Michalowicz R, Ignatowicz R, Kostrzewska M (1983) [Familial occurrence of subacute sclerosing panencephalitis (SSPE) in children]. Neurol Neurochir Pol 17: 651-654.
38. Michalowicz R, Karkowska B, Ignatowicz R, Michalkiewicz J, Wyszkowski J (1985) Subacute sclerosing panencephalitis in twins. Acta Paediatr Hung 26: 97-99.
39. Tuxhorn IE (2004) Familial subacute sclerosing panencephalitis in two siblings. Pediatr Neurol 31: 291-294.
40. Vieker S, Schmitt JJ, Behrens C, Weissbrich B, Hartmann H (2003) Subacute sclerosing panencephalitis in two brothers. Neuropediatrics 34: 326-329.
41. Sharma V, Gupta VB, Eisenhut M (2008) Familial subacute sclerosing panencephalitis associated with short latency. Pediatr Neurol 38: 215-217.
42. Inoue T, Kira R, Nakao F, Ihara K, Bassuny WM, et al. (2002) Contribution of the interleukin 4 gene to susceptibility to subacute sclerosing panencephalitis. Arch Neurol 59: 822-827.
43. Torisu H, Kusuhara K, Kira R, Bassuny WM, Sakai Y, et al. (2004) Functional MxA promoter polymorphism associated with subacute sclerosing panencephalitis. Neurology 62: 457-460.
44. Yilmaz V, Demirbilek V, Gurses C, Yentur SP, Uysal S, et al. (2007) Interleukin (IL)-12, IL-2, interferon-gamma gene polymorphisms in subacute sclerosing panencephalitis patients. J Neurovirol 13: 410-415.
45. Pipo-Deveza JR, Kusuhara K, Silao CL, Lukban MB, Salonga AM, et al. (2006) Analysis of MxA, IL-4, and IRF-1 genes in Filipino patients with subacute sclerosing panencephalitis. Neuropediatrics 37: 222-228.
46. Miller C, Farrington CP, Harbert K (1992) The epidemiology of subacute sclerosing panencephalitis in England and Wales 1970-1989. Int J Epidemiol 21: 998-1006.
47. Yilmaz C, Caksen H, Yilmaz N, Guven AS, Bayram I (2007) Two cases of subacute sclerosing panencephalitis associated with brainstem involvement. J Trop Pediatr 53: 280-283.
48. Aaby P, Andersen M, Knudsen K (1993) Excess mortality after early exposure to measles. Int J Epidemiol 22: 156-162.